Skip to content

Mobility Training Using a Bionic Knee Orthosis in Patients Chronic Post-Stroke: A Case Series

Discriminatory Neurosensory Stimulation Neurological H5394-11417-15

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01499862
Enrollment
3
Registered
2011-12-26
Start date
2009-06-30
Completion date
2011-12-31
Last updated
2013-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Tibion, Bionics, Rehab, Therapy, Robotics, Intention

Brief summary

This pilot study examined the effect of task-oriented mobility training in three persons chronic post-stroke using a novel, wearable, mobile intention-based robotic orthosis (Tibion Bionic Leg).

Interventions

A programmable, carbon-fiber robotic leg orthosis (Tibion Bionic Leg, Tibion Corporation, Sunnyvale, CA) was used during therapy to actively supplement concentric and eccentric quadriceps function on the participant's impaired side. The device uses internal sensors at the foot and knee joint to detect intention of movement and, once a variable force threshold is passed, the devices provides appropriate assistive and resistive adjustments.

Sponsors

University of California, San Francisco
CollaboratorOTHER
Tibion Bionics, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Male or female * Aged 40 to 60 years * One year status post-stroke * Able to walk at least 10 meters * Independence in self-care

Exclusion criteria

* Medically unstable * Major cardiopulmonary deficiency * Major depression * Significant cognitive deficit * Currently receiving gait training * Younger than 40 years of age * Older than 60 years of age * Unable to walk at least 10 meters

Design outcomes

Primary

MeasureTime frameDescription
Ambulation SpeedBaseline (prior to training); at conclusion of 4 week training regimen (1.5 hours/session with 2 to 4 sessions per week); and 1 Month post-training regimen.Ambulation speed, in meters per second, as obtained by the Ten (10) Meter Walk Test (10 MWT). The 10 MWT measures the time required to walk 10 meters at the subject's comfortable walking pace.

Secondary

MeasureTime frameDescription
6 Minute Walk Test (6 MWT)Baseline (prior to training); at conclusion of 4 week training regimen (1.5 hours/session with 2 to 4 sessions per week); and 1 Month post-training regimen.The total distance walked by the patient, in meters, as obtained by the Six (6) Minute Walk Test (6 MWT). The 6 MWT is performed over level ground, using any walking aids (canes, walkers, etc.) the patient requires for comfortable walking.
Timed Up and Go (TUG) TestBaseline (prior to training); at conclusion of 4 week training regimen (1.5 hours/session with 2 to 4 sessions per week); and 1 Month post-training regimen.The time, in seconds, for the patient to rise from sitting in a standard arm chair, walk 3 meters, turn around, walk back to the chair, and sit down. This evaluation is called the Timed Up and Go test (TUG). The patient may wear their usual footwear and use any aids (canes, walkers, etc.) they typically employ for comfortable walking.
Five Times Sit to Stand Test (5 x STS)Baseline (prior to training); at conclusion of 4 week training regimen (1.5 hours/session with 2 to 4 sessions per week); and 1 Month post-training regimen.The time, in seconds, for the patient to rise from a seated to full standing position and return to sitting five times in rapid succession. This evaluation is called the Five Times Sit to Stand Test (5 x STS)
Step LengthBaseline (prior to training); at conclusion of 4 week training regimen (1.5 hours/session with 2 to 4 sessions per week); and 1 Month post-training regimen.The length of the patient's average step, in meters, as measured during comfortable walking.

Countries

United States

Participant flow

Recruitment details

Patients were part of the hospitals patient population.

Participants by arm

ArmCount
All Participants
All subjects had reached plateau with conventional Bodyweight-Supported Treadmill Training (BWSTT, participated in task-oriented mobility therapy(1.5 hours, 2-4 times per week for 4 weeks) with Robotic Leg Orthosis (RLO) under the supervision of a physical therapist.
3
Total3

Baseline characteristics

CharacteristicAll Participants
Age Continuous50 Years
Lower Left Extremity Strength105 Pounds-Force
Resting Extensor Tone (Modified Ashworth Scale)
Mean Ankle Score
2 Units on a Scale
Resting Extensor Tone (Modified Ashworth Scale)
Mean Knee Score
3 Units on a Scale
Right Lower Extremity Strength105 Pounds-Force
Sex: Female, Male
Female
2 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 3
serious
Total, serious adverse events
0 / 3

Outcome results

Primary

Ambulation Speed

Ambulation speed, in meters per second, as obtained by the Ten (10) Meter Walk Test (10 MWT). The 10 MWT measures the time required to walk 10 meters at the subject's comfortable walking pace.

Time frame: Baseline (prior to training); at conclusion of 4 week training regimen (1.5 hours/session with 2 to 4 sessions per week); and 1 Month post-training regimen.

Population: Three (3) Subjects all of whom had a plateaued with conventional Bodyweight-Supported Treadmill Training (BWSTT) participated in task-oriented mobility therapy (1.5 hours, 2-4 times per week for 4 weeks) with the Tibion Bionic Leg under the supervision of a physical therapist.

ArmMeasureGroupValue (NUMBER)
Patient 1Ambulation SpeedEnd of Training0.81 meters per second (m/s)
Patient 1Ambulation SpeedBaseline0.60 meters per second (m/s)
Patient 1Ambulation Speed1 Month Post-Training0.95 meters per second (m/s)
Patient 2Ambulation SpeedEnd of Training0.43 meters per second (m/s)
Patient 2Ambulation SpeedBaseline0.29 meters per second (m/s)
Patient 2Ambulation Speed1 Month Post-Training0.45 meters per second (m/s)
Patient 3Ambulation SpeedBaseline0.83 meters per second (m/s)
Patient 3Ambulation Speed1 Month Post-Training1.14 meters per second (m/s)
Patient 3Ambulation SpeedEnd of Training1.03 meters per second (m/s)
Secondary

6 Minute Walk Test (6 MWT)

The total distance walked by the patient, in meters, as obtained by the Six (6) Minute Walk Test (6 MWT). The 6 MWT is performed over level ground, using any walking aids (canes, walkers, etc.) the patient requires for comfortable walking.

Time frame: Baseline (prior to training); at conclusion of 4 week training regimen (1.5 hours/session with 2 to 4 sessions per week); and 1 Month post-training regimen.

Population: Three (3) Subjects all of whom had a plateaued with conventional Bodyweight-Supported Treadmill Training (BWSTT) participated in task-oriented mobility therapy (1.5 hours, 2-4 times per week for 4 weeks) with the Tibion Bionic Leg under the supervision of a physical therapist.

ArmMeasureGroupValue (NUMBER)
Patient 16 Minute Walk Test (6 MWT)End of Training207 Meters
Patient 16 Minute Walk Test (6 MWT)Baseline170 Meters
Patient 16 Minute Walk Test (6 MWT)1 Month Post-Training250 Meters
Patient 26 Minute Walk Test (6 MWT)End of Training140 Meters
Patient 26 Minute Walk Test (6 MWT)Baseline93 Meters
Patient 26 Minute Walk Test (6 MWT)1 Month Post-Training123 Meters
Patient 36 Minute Walk Test (6 MWT)Baseline271 Meters
Patient 36 Minute Walk Test (6 MWT)1 Month Post-Training285 Meters
Patient 36 Minute Walk Test (6 MWT)End of Training300 Meters
Secondary

Five Times Sit to Stand Test (5 x STS)

The time, in seconds, for the patient to rise from a seated to full standing position and return to sitting five times in rapid succession. This evaluation is called the Five Times Sit to Stand Test (5 x STS)

Time frame: Baseline (prior to training); at conclusion of 4 week training regimen (1.5 hours/session with 2 to 4 sessions per week); and 1 Month post-training regimen.

Population: Three (3) Subjects all of whom had a plateaued with conventional Bodyweight-Supported Treadmill Training (BWSTT) participated in task-oriented mobility therapy (1.5 hours, 2-4 times per week for 4 weeks) with the Tibion Bionic Leg under the supervision of a physical therapist.

ArmMeasureGroupValue (NUMBER)
Patient 1Five Times Sit to Stand Test (5 x STS)1 Month Post-Training11.1 Seconds
Patient 1Five Times Sit to Stand Test (5 x STS)End of Training10.5 Seconds
Patient 1Five Times Sit to Stand Test (5 x STS)Baseline12.1 Seconds
Patient 2Five Times Sit to Stand Test (5 x STS)1 Month Post-Training13.2 Seconds
Patient 2Five Times Sit to Stand Test (5 x STS)Baseline12.4 Seconds
Patient 2Five Times Sit to Stand Test (5 x STS)End of Training13.0 Seconds
Patient 3Five Times Sit to Stand Test (5 x STS)End of Training12.2 Seconds
Patient 3Five Times Sit to Stand Test (5 x STS)Baseline11.4 Seconds
Patient 3Five Times Sit to Stand Test (5 x STS)1 Month Post-Training10.1 Seconds
Secondary

Step Length

The length of the patient's average step, in meters, as measured during comfortable walking.

Time frame: Baseline (prior to training); at conclusion of 4 week training regimen (1.5 hours/session with 2 to 4 sessions per week); and 1 Month post-training regimen.

Population: Three (3) Subjects all of whom had a plateaued with conventional Bodyweight-Supported Treadmill Training (BWSTT) participated in task-oriented mobility therapy (1.5 hours, 2-4 times per week for 4 weeks) with the Tibion Bionic Leg under the supervision of a physical therapist.

ArmMeasureGroupValue (NUMBER)
Patient 1Step LengthBaseline0.49 Meters
Patient 1Step Length1 Month Post-Training0.59 Meters
Patient 1Step LengthEnd of Training0.56 Meters
Patient 2Step LengthBaseline0.29 Meters
Patient 2Step Length1 Month Post-Training0.39 Meters
Patient 2Step LengthEnd of Training0.40 Meters
Patient 3Step Length1 Month Post-Training0.60 Meters
Patient 3Step LengthEnd of Training0.59 Meters
Patient 3Step LengthBaseline0.54 Meters
Secondary

Timed Up and Go (TUG) Test

The time, in seconds, for the patient to rise from sitting in a standard arm chair, walk 3 meters, turn around, walk back to the chair, and sit down. This evaluation is called the Timed Up and Go test (TUG). The patient may wear their usual footwear and use any aids (canes, walkers, etc.) they typically employ for comfortable walking.

Time frame: Baseline (prior to training); at conclusion of 4 week training regimen (1.5 hours/session with 2 to 4 sessions per week); and 1 Month post-training regimen.

Population: Three (3) Subjects all of whom had a plateaued with conventional Bodyweight-Supported Treadmill Training (BWSTT) participated in task-oriented mobility therapy (1.5 hours, 2-4 times per week for 4 weeks) with the Tibion Bionic Leg under the supervision of a physical therapist.

ArmMeasureGroupValue (NUMBER)
Patient 1Timed Up and Go (TUG) TestEnd of Training14.5 Seconds
Patient 1Timed Up and Go (TUG) TestBaseline21.4 Seconds
Patient 1Timed Up and Go (TUG) Test1 Month Post-Training12.4 Seconds
Patient 2Timed Up and Go (TUG) TestEnd of Training23.3 Seconds
Patient 2Timed Up and Go (TUG) TestBaseline21.4 Seconds
Patient 2Timed Up and Go (TUG) Test1 Month Post-Training24.0 Seconds
Patient 3Timed Up and Go (TUG) TestBaseline9.14 Seconds
Patient 3Timed Up and Go (TUG) Test1 Month Post-Training10.1 Seconds
Patient 3Timed Up and Go (TUG) TestEnd of Training8.94 Seconds

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026